Sinovac Biotech Ltd (NASDAQ:SVA)

--
Delayed Data
As of --
-- -- / --
Today’s Change
--
|||52-Week Range
--
--
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$653.7M

Company Description

Sinovac Biotech Ltd. is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. Its product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza, H1N1 influenza, and mumps. The company was founded in 1993 and is headquartered in Beijing, China.

Contact Information

Sinovac Biotech Ltd.
No. 39 Shangdi Xi Road
Beijing Beijing 100085
P:861056931800
Investor Relations:
861082799871

Employees

Shareholders

Mutual fund holders0.00%
Other institutional0.00%
Individual stakeholders--

Top Executives

Wei Dong YinChairman, President, CEO, Secretary & MD
Qiang GaoChief Operating Officer & Vice President
Nan WangCFO & Vice President-Business Development
Xiao Mei YinVice President-Sales & Marketing
Coco ChangHead-International Sales